Australia's most trusted
source of pharma news
Friday, 20 March 2026
Friday, 20 March 2026
Subscribe
Login
CEO's $29 million Swan Song
Exiting on a high note, this former CEO won a 50 per cent pay hike in her final year in the job for 'outstanding leadership' and will continue earning big bucks until later this year.
A dozen drugs hit listing limbo
ICYMI: Twelve drugs from the PBAC's November meeting stall plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Companies ready to file new drugs
Novel drugs and new indications are set to be filed in Australia after the TGA handed out the first pathways for registration for 2026
TODAY
20 drugs jostle for April PBS slots
Eight new drugs could make their first appearance on the PBS next month along with a first biosimilar and a raft of new indications
19 March
Novo slapped with Warning Letter
The TGA is "considering issues raised" in an FDA warning letter to Novo Nordisk over unreported semaglutide safety signals
19 March
'Bad juju' crashes Aussie company
A delayed announcement of a trial discontinuation has wiped 90 per cent from this company's market cap
18 March
World's top drug, by a loophole
This drug brought in a handsome haul last year and seemed to be holding a comfortable lead but was it a win on a technicality?
18 March
Latest Jobs
Brand ManagerCorporate Operations ManagerWarehouse AssistantCustomer Service RepresentativePractice ManagerRegulatory Affairs SpecialistAccount ManagerDirector of Operations17 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (7)
- Customer Service Representative - St Leonards
- Account Manager - Sydney
- Business Development Manager | Community Care - Queensland
- Pharmaceutical Sales Representative - Sydney
- Devices Account Manager - Sydney
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
Clinical & Medical, R&D (2)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Clinical Project Manager - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Specialist - Lane Cove
- Pharmacovigilance Associate - Sydney
- Regulatory Affairs Specialist - Glenorie
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
Devices (1)
Executive Roles (4)
- Director of Operations - Melbourne
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
Other (9)
- Corporate Operations Manager - Sydney, NSW
- Warehouse Assistant - Macquarie Park
- Practice Manager - Sydney
- Senior Recruitment Consultant - Sydney
- Pharmacy Storeperson - Toongabbie
- Warehouse Assistant - Eight Mile Plains
- Materials Planner - North Ryde
- Procurement Specialist - New South Wales
- Finance & Administration Officer - Macquarie Park
A-list attends Sanofi office opening
Official opening of the company's new Aussie headquarters in Barangaroo, caps off the milestone move from Macquarie Park
TODAY
Novo rolls out Aussie-first recycling
Company signs a memorandum of understanding with pharmacies and hospitals to cut waste and keep valuable materials out of landfill
TODAY
Oncology-focused team launches
An Australian duo have joined forces to offer pharma and biotech a single, coordinated team to accelerate clinical trials
19 March
Global high-flyer lands Aussie gig
Ex-J&J, Sanofi and Takeda exec appointed to drive international approvals and sales, expanding this product range to 10 countries
19 March
Who's taken home an MA Award?
The industry body has recognised those showing capability, professionalism, and commitment to ethical practice
19 March
Locals improve CAR T therapy
The TGA has approved trials for a CAR T-cell therapy targeting a different receptor, improving the safety profile of the treatment
18 March
PBAC lets slip reason for 'go-slow'
The PBAC has revealed why it is dragging its heels in recommending a much-in-demand class of drugs, instead aiming for a "slow roll-out"
18 March
Australia lines up for RNA first
US company hopes to secure approval for its lead product in Australia within the next 12 months, and in other major markets in 2027
18 March
Novo CEO taps Australia to lead
Before shaking hands with Danish Royalty, Novo CEO Mike Doustdar touted an 'Australian-made' solution to the obesity epidemic
17 March
Arrotex inks cardio drug deal
Aussie duo aims to commercialise a new triplet combo therapy for hypertension in Australia and New Zealand as early as next year
17 March
Meet pharma's newest blockbuster
A still-growing dual inhibitor almost quadrupled annual sales to scream into blockbuster territory, and it's showing up in PBS reimbursements
17 March
Seqirus takes jab to private market
Just in time for the upcoming flu season, CSL Seqirus has won TGA approval for its influenza vaccine in a younger adult cohort
17 March
Novartis quizzes Aussies on MS
National survey lifts the lid on entrenched public misconceptions about the condition with some alarming findings taking their toll
17 March
CEO pay packet rockets by 75%
In his second year in the job, this big pharma CEO has hit the big league, with his compensation package soaring
16 March